Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
71
Views
4
Downloads
Abstract
Chronic otitis media is a long-term disorder of the pars tensa or flaccida (COM). Having long-term middle ear mucosal inflammation. The main set of symptoms for the mucosal variety of COM is intermittent discharge from the ear along with tympanic membrane (TM) rupture and conductive hearing loss. To find out the success rate of type I tympanoplasty with or without canalplasty regarding graft uptake in both groups. The present study Prospective, longitudinal study, at the Department of Otorhinolaryngology and Head Neck Surgery, of Calcutta National Medical College and Hospital. It’s conducted from 18 months (MARCH 2015 - AUGUST 2016), 40 patients were included in this study. Patients were divided in two groups. In 20 patients, canalplasty along with type Itympanoplasty were undertaken and in rest 20 patients, only type I tympanoplasty were performed without canalplasty. The Patients aged between 18 to 50 years attending out-patient department of Otorhinolaryngology, Calcutta National Medical College and Hospital with unilateral inactive mucosal variety of chronic otitis media with central perforation.Result: It is observed that mean improvement in the Group A undergoing canalplasty is 14.21 dB and in the group with only tympanoplasty it is 9.65 dB only. So additional hearing gain is 4.56 dB (12.31%). Our research concludes that both type I tympanoplasty and canalplasty are useful in enhancing middle ear function and hearing outcomes in individuals with chronic otitis media with inactive mucosal disease. But compared to patients who had tympanoplasty alone, we found that individuals who had canalplasty in addition to tympanoplasty had marginally improved postoperative air-bone gap closure and hearing improvement.
How to cite this article:
Sandipan Naskar and Soumik Saha. Clinico-Audiological Comparison Between Type I Tympanoplasty with and Without Canalplasty in Patients of Chronic Otitis Media with Inactive Mucosal Disease.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.18.1.577.580
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.18.1.577.580